- Stressed and Distracted, Kids and Their Teachers Say Virtual Learning Isn’t Working
- Fauci Says U.S. Will Stay With Two Doses of Pfizer, Moderna Vaccines
- Health Highlights, March 2, 2021
- Many Blacks, Hispanics Believe They’ll Get Worse Care If Dementia Strikes
- For Some Young Drivers, Smartphone Use Is One of Many Bad Habits
- Strep Throat Doesn’t Worsen Tourette But May Affect ADHD: Study
- Sports Position Doesn’t Affect Risk of Concussion-Linked CTE Illness
- ‘Telestroke’ Care at Hospitals Is Boosting Patient Outcomes
- Face Masks Won’t Impede Your Breathing, Study Confirms
- Pot May Not Be the Best Rx for a Migraine
Clinical Trials Update: July 22, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Rheumatoid Arthritis
This study of an investigational drug is for people who now take Methotrexate for rheumatoid arthritis.
The research site is in Worcester, Mass.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/rheumatoid_arthritis.aspx.
—–
Pediatric Migraine
This study will evaluate an investigational drug to treat migraines in children. Participants must be between 12 and 17 and have had migraines for at least six months.
The research site is in Duluth, Ga.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/migraine.aspx.
—–
Type 2 Diabetes
If you qualify for this type 2 diabetes study, you will receive study medication and study-related health evaluations at no cost, and possible reimbursement for time and travel.
The research site is in Scarborough, Maine.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/diabetes.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
